Lauren Randall Buckley is the Group Vice President of Health Policy and Reimbursement at Jeffrey J. Kimbell & Associates in Washington, D.C. She has spent her career representing innovative healthcare technology companies before the Administration and Congress on cutting-edge federal regulatory, policy, and legislative issues.
Ms. Buckley’s practice at Kimbell & Associates focuses on providing strategic advice on health policy and reimbursement matters, as well as representing clients before the Centers for Medicare and Medicaid Services (CMS) and other key policy stakeholders. She possesses extensive experience in assisting clients with navigating complex Medicare and Medicaid coverage, coding, and payment issues; engaging on payment and delivery system reform issues; and developing commercialization strategies.
Ms. Buckley has successfully represented companies in obtaining HCPCS, CPT, and ICD-10-CM diagnosis codes, as well as Medicare Part B Transitional Pass-through Payment Status under the Hospital Outpatient Prospective Payment System. She also has assisted companies in developing strategies for mitigating coverage challenges, as well as technical coding and payment policy issues.
Prior to joining Kimbell & Associates, Ms. Buckley led the U.S. federal health policy portfolio and served as a federal lobbyist for MedImmune, a biotechnology company that is now part of AstraZeneca. Before joining MedImmune, Ms. Buckley practiced law for many years in the Healthcare Regulatory practice group at Sidley Austin LLP. She began her career as an associate in the Washington, D.C. office of DLA Piper.
Learn more about the our Crossroads 2020 Speakers!
As a reporter who didn't start covering pharma until 2016, I really appreciated this great roundup of important drug approvals of last decade, from @adamfeuerstein n @matthewherper